Off label use of Aripiprazole shows promise as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Crosby et al. 2021

[SugarSquared]

Abilify is finally getting a new trial in LC/ME/CFS, though it seems to have some less-than-ideal study design. At least it's double-blind and placebo-controlled.

Post-acute Infectious Syndrome - Aripiprazole Symptom Evaluation (PAIS-AriSE)